ACTRN12611000104954终止1 期
Combination Gefitinib and Methotrexate for the Treatment of Persistent Gestational Trophoblastic Disease: A Phase I Clinical Trial
Miss Orla McNally, Director Gynaecological Oncology & Dysplasia0 个研究点目标入组 12 人开始时间: 2011年1月31日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- Female
入选标准
- •Persistent gestational trophoblastic disease diagnosed on tissue histopathology and confirmed by persistence of serum beta human chorionic gonadotropin levels.
排除标准
- •Chronic pulmonary disease (excluding mild asthma), severe gastrointesitinal or dermatological disease, Japanese ethinicity, allergy to methotrexate or gefitinib.
研究者
相似试验
已完成
1 期
Combination Gefitinib and Methotrexate to Medically Treat Ectopic Pregnancies: A Phase I Clinical Toxicity Trial.Clinically stable ectopic pregnanciesReproductive Health and Childbirth - Other reproductive health and childbirth disordersACTRN12610000684022Dr Stephen Tong12
招募中
2 期
Combination Gefitinib and Methotrexate to Medically Treat Ectopic Pregnancies: A Phase II Study of EfficacyACTRN12611001056987Associate Professor Stephen Tong40
进行中（未招募）
1 期
GEM study for ectopic pregnancyEUCTR2011-001747-69-GBMonash University30
尚未招募
3 期
Comparison of effectiveness and tolerance of Single drug Methotrexate or Combination of drugs i.e. Methotrexate and Gefitinib drug in patients with very advanced head and neck cancerCTRI/2021/04/032577JIPMER
已完成
不适用
Clinical study of a combined use of Gefitinib and autologous lymphocyte-activated killer cells (LAK) therapy for advanced non-small cell lung cancer.non-small cell lung cancerJPRN-UMIN000000637Juntendo University, School of Medicine20